Načítá se...
TGF-β signaling in the kidney: profibrotic and protective effects
Transforming growth factor-β (TGF-β) is generally considered as a central mediator of fibrotic diseases. Indeed, much focus has been placed on inhibiting TGF-β and its downstream targets as ideal therapeutic strategies. However, pharmacological blockade of TGF-β has not yet translated into successfu...
Uloženo v:
| Vydáno v: | Am J Physiol Renal Physiol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Physiological Society
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4824143/ https://ncbi.nlm.nih.gov/pubmed/26739888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00365.2015 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|